Ok, so there wasn’t really a war on at the 4th PDA Europe Workshop on Monoclonal Antibodies, though there was plenty of mildly heated discussion. I simply could not resist the Lucas reference.
Conducted in Basel (Switzerland) in mid-June, the workshop was fully attended, but relatively small, such that it could “foster a feeling of closeness and networking”, according to Richard Levy, senior vice president, scientific and regulatory affairs at the Parenteral Drug Association (PDA). And indeed it did; the numerous coffee breaks were a great opportunity for industry peers and regulators to mix and continue discussions initiated in presentations. Perhaps any bigger, and the sense of relaxed community would be lost… Read more »